Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

U.S. clinical stroke trial supports efficacy and safety of citicoline

Nov. 6, 1997

Patient enrollment complete for phase II trial of memantine

Nov. 6, 1997

FDA approves generic formulation of oxycodone/acetaminophen

Nov. 6, 1997

First market introduction for dolasetron

Nov. 6, 1997

New alpha2-adrenoceptor agonists from Synaptic

Nov. 5, 1997

New glycine-site NMDA partial agonist from ADIR

Nov. 5, 1997

MCI-186: Mitsubishi Chemical's new candidate for acute stroke

Nov. 5, 1997

Sequana and Parke-Davis collaborate on drug discovery for CNS

Nov. 5, 1997

U.S. patent issued for ABS 200 series

Nov. 4, 1997

Effects of riluzole on ischemia-induced glutamate accumulation in rabbits

Nov. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...